Filing metadata

Accession number
0001193125-14-064986
Form type
SC 13G
Filer
Revance Therapeutics, Inc.
CIK
CIK 1479290
Filed
Feb 24, 2014
Reporting period
Feb 14, 2014
Description
Passive 5%+ stake

Explore SEC Filings Hub